Recent molecular studies on the Rh blood group system have shown that the Rh locus of each haploid RhD-positive chromosome is composed of two structural genes: RHD and RHCE , whereas the locus is made of a single gene ( RHCE ) on each haploid RhD-negative chromosome. We analyzed the presence or absence of the RHD gene in 130 Japanese RhD-negative donors using the PCR method. The RhDnegative phenotypes consisted of 34 ccEe, 27 ccee, 17 ccEE, 26 Ccee, 19 CcEe, 1 CcEE, and 6 CCee. 
Introduction
Recent studies of the Rh blood group system have shown that RH genes are composed of RHD and RHCE genes (1) (2) (3) (4) (5) . It is inferred that the RHD gene encodes the RhD antigen, and that the RHCE gene encodes the Rh C/c and RhE/e antigens (1) (2) (3) (4) (5) . The Rh system is one of the clinically important blood groups because it induces Rh-incompatible blood transfusion and hemolytic disease of the newborn (HDN) 1 (6) . To make a rapid diagnosis and achieve a good prognosis, especially in HDN, it is necessary to investigate fetal RhD type before birth. In the case of patients who have been recently transfused, and who harbor a large quantity of donor blood cells, it is sometimes difficult to determine the Rh phenotypes with accuracy. Therefore, various trials were carried out to determine the genotypes of the Rh blood group system. Several groups applied RFLP patterns on Southern blots for Rh genotyping (1, 7, 8) . Recently, PCR experiments have been used to examine the Rh genotypes (9) (10) (11) (12) . Some of these methods have been put in practice. Among them, RhD genotyping has spread widely.
The method for RhD genotyping is based on the presence or absence of the RHD gene (9, 11) . The RHD gene structure is not yet known completely, but preliminary investigations indicate that it resembles closely the RHCE gene that comprises 10 exons ranging in size from 72 to 247 bp distributed over 75 kb (13) . A deletion of 600 bp in intron 4 of the RHD gene, however, and sequence divergences between the RHD and RHCE genes in the 3 Ј noncoding region, have been identified (2, 3) . Substitutions of 41 bp between RhD and RhCE cDNA were indicated. On the basis of features of the RHD gene, several RhD genotypings have been performed by PCR, and have demonstrated some cases with discrepancies between RhD serotyping and genotyping (11) . Hyland et al. (14) investigated three RhD-negative samples with the CCee phenotype in the Australian population, and found that one appeared to have a normal RHD gene. We also detected the RHD gene in RhDnegative Japanese individuals (15, 16) . Simsek et al. (11) have reported no detection of the RHD gene in 56 RhD-negative Caucasians. These results suggest that racial differences exist in the genetic background of the RhD antigen, and call our attention to RhD genotyping. The exact frequency of RhD-negative Japanese individuals with the RHD gene has not been clarified. For the purpose of determining the gene frequency and examining its disparity between Japanese and Caucasians, we analyzed the RHD gene in 130 unrelated RhD-negative Japanese donors. The gene's incidence is higher than we expected. We would like to report the result, and to discuss the racial difference.
Methods
Blood sample. We have analyzed genomic DNAs from 200 RhDpositive and 130 RhD-negative unrelated Japanese donors. Anticoagulated whole blood was drawn from the cubital vein after informed consent. Serotyping for the RhD, RhC/c, and RhE/e antigens was carried out by polyclonal and monoclonal anti-RhD (Ortho Diagnostic Systems Inc., Raritan, NJ, and Osaka Red Cross Center, Osaka, Japan), and polyclonal anti-C, anti-c, anti-E, and anti-e antibodies (Ortho Diagnostic Systems Inc.).
RNA and DNA isolation. Total RNAs of reticulocytes were isolated according to Tse et al. (17) . Genomic DNA was extracted from peripheral blood leukocytes according to a previously reported method (18) .
PCR for RHCE and RHD genes. Table I shows the PCR primers for detection of RH gene. To investigate the promoter regions in the RHD and RHCE genes, PCR amplification was performed by a set of primers: Ps (CCAGGTTTTTACTAGAGCCA) and Pa (AGAGCT-GCTTCCAGTGTTAG). Primer F3 for a sequence located in exon 4, and primer R3 for a sequence located in exon 5, were used to distinguish the RHCE and RHD genes ( Fig. 1 , Table I ). The antisense primer R6 recognizes a sequence in the 3 Ј noncoding region of the RHD gene (2), and therefore yields a product of 198 bp (Fig. 1 , Table I ).
In the presence of all four primers (F3/R3 and F6/R6), dual PCRI was performed. By making use of the differences in RhD cDNA as compared with RhCE cDNA, six primers (F2/R2, F4/R4, and F5/R5) specific to the RHD gene were produced (Fig. 1 , Table I ). Two primers (F1/R1) to exon 2 were common to both RHD and RHCE genes, and were used as an internal control to validate the PCR reaction (Fig. 1 , Table I ). As shown in Fig. 1 , eight primers (F1/R1, F2/R2, F4/R4, and F5/R5) were applied to allele-specific amplification for detecting the RHD gene. Dual PCRII was used in the presence of four primers (F1/R1 and F5/R5) to detect exon 7 of the RHD gene and triple PCR was carried out with six primers (F1/R1, F2/R2, and F4/R4) to identify exons 3 and 5 of the RHD gene.
Reverse transcription-PCR (RT-PCR). Poly(A)
ϩ RNA was reverse transcribed into the first strand of cDNA with oligo(dT) 16 as a primer using cloned Moloney murine leukemia virus reverse transcriptase. PCR was performed in a reaction tube (Gene Amp RNA PCR kit; Perkin Elmer Corp., Norwalk, CT). The two primers prepared for PCR and sequencing on the basis of the published cDNA sequence of Rh polypeptides (19, 20) were as follows: 1s (nt Ϫ 30 to Ϫ 11); 5 Ј -GTGGAACCCCTGCACAGAGA-3 Ј , and 1a (nt 1283 to 1264); 5 Ј -CAGGCCTTGTTTTTCTTGGA-3 Ј .
PCR condition. Three kinds of PCR were performed with the genomic DNA in the capacity of the template, as follows. Method I was used in analyzing the promoter region (primers Ps/Pa), for carrying out dual PCRI (primers F3/R3 and F6/R6) and RT-PCR (primers 1s/ 1a). Final concentration was 1 ϫ PCR buffer (10 ϫ PCR buffer ϭ 15 mM MgCl 2 , 100 mM Tris-HCl pH 8.3, 500 mM KCl buffer), 0.24 M of both 5 Ј and 3 Ј primer, and 2.5 U Taq DNA polymerase in a total volume of 100 l. The first cycle of the PCR was done at 95ЊC for 5 min to denature DNA, followed by 35 cycles of 1 min at 95ЊC, 1 min at 55ЊC, and 3 min at 72ЊC, and finally, 1 cycle of 10 min at 72ЊC.
Method II was applied to dual PCRII (primers F1/R1 and F5/R5) for detecting exon 7 of the RHD gene. PCR mixture was of the same composition as that in method I. After an initial cycle of denaturation at 95ЊC for 5 min, 40 cycles were performed, consisting of 1 min of denaturation at 95ЊC, 1.5 min of primer annealing at 55ЊC, 3 min of extension at 72ЊC, followed by a final cycle of 10 min at 72ЊC. Method III was fulfilled for identifying exons 3 and 5 of the RHD gene. Final concentration of PCR mixture was 1ϫ PCR buffer (same as above), 1.5 M of both 5Ј and 3Ј primers, and 5.0 U Taq DNA polymerase in a total volume of 100 l. The first cycle of PCR was done at 95ЊC for 5 min to denature DNA, followed by 35 cycles of 30 s at 95ЊC (denaturation), 30 s at 67ЊC (annealing), 30 s at 72ЊC (extension), and finally, 1 cycle of 10 min at 72ЊC. To evaluate all results of amplification by methods I, II, and III, 5 l of the reaction mixture was withdrawn and electrophoresed in 3% agarose gel. Subcloning. PCR products of intron 4 were ligated into pCRTM II (TA cloning kit; Invitrogen Corp., San Diego, CA) according to the supplier's instructions. After transformation, the clones with the insert were screened by color selection with X-Gal. Each white colony was transferred into Luria-Bewtani medium containing ampicillin at 100 g/ml, and the culture was incubated overnight at 37ЊC. Plasmid DNAs were isolated by the alkaline lysis method, and were prepared for sequencing by the alkaline-denaturation method. DNA sequencing and analysis. The ssDNA template was sequenced by the dideoxy chain termination of Sanger et al. (21) using a Sequenase manufacturer. The primers used were either sequencespecific oligonucleotides, or the universal primer. The reaction products were electrophoresed on 6% acrylamide gels containing 8 M urea.
Southern analysis. Genomic DNAs obtained were digested with restriction endonuclease BamHI and analyzed by Southern blot hybridization as described (8) . The RHD-cDNA in the coding region was used as a probe.
Results
Determination of Rh phenotypes. RhD phenotyping of unrelated Japanese donors was performed by polyclonal and monoclonal anti-RhD antibodies. In the case of detecting no agglutination, antiglobulin and adsorption/elution tests were performed to exclude weak D, D u , or D el antigen (22) . The RhD-negative phenotypes were determined through such a process. As regards partial D, the screening test was performed according to the strategy of Okubo et al. (23) . Additionally, the phenotypes of RhC/c and RhE/e were observed. In this study, we analyzed 200 RhD-positive donors and 130 RhD-negative donors. The RhD-negative phenotypes consisted of 34 ccEe, 27 ccee, 17 ccEE, 26 Ccee, 19 CcEe, 1 CcEE, and 6 CCee.
Isolation and sequencing of intron 4 of the RHD and RHCE genes. The RHCE gene is composed of 10 exons (13). The RHD gene structure has not been established, but preliminary investigations indicated that it is similarly organized (13). Recently, a deletion of 600 bp in intron 4 of the RHD gene was identified. Huang showed all sequences of intron 4 in the RHD gene, and indicated the existence of the human Alu repeat in intron 4 of the RHCE gene (24) . Westhoff et al. demonstrated the Alu element similar to Huang's report in addition to all sequences of intron 4 in both the RHD and RHCE genes (25) . To identify intron 4 of the RHD gene and the RHCE genes, we carried out the PCR amplification with primers F3/R3. As shown in Fig. 2 , intron 4 of the RHCE and RHD genes consisted of 1,075 and 426 nucleotides, respectively. The size of deletion in intron 4 of the RHD gene was 649 bp. It was confirmed that the difference in size between intron 4 fragments of the RHCE and RHD genes derives from a deletion, and that the nondeleted sequence of the RHD gene is identical to the RHCE gene except for three nucleotides. The nucleotide sequence of intron 4 in the RHD gene was entirely consistent with that reported by Huang. Comparing our data with the report of Westhoff et al. (25) , however, there are many nucleotide differences: two deletions (G at nucleotide 1, A at nucleotide 316), a single insertion (G next to nucleotide 426) in intron 4 of the RHD gene, four deletions (G at nucleotide 1, G at nucleotide 545, C at nucleotide 953, A at nucleotide 965), four insertions (G at nucleotide 308, A at nucleotide 409, G at nucleotide 414, G next to nucleotide 1075), and three substitutions (C→T at nucleotide 308, A→G at nucleotide 685, G→A at nucleotide 799) in intron 4 of the RHCE gene (Fig. 2) .
Detection of the RHD gene by PCR. For detecting the presence or absence of the RHD gene, the PCR amplification for intron 4 of the RHD and RHCE genes was performed by primers F3/R3. In addition to the primer set for intron 4, another primer set (F6/R6) was prepared that is specific for exon 10 of the RHD gene only. The dual PCRI was done by these two primer sets (F3/R3 and F6/R6) (Fig. 1) . All 200 RhD-positive donors showed three PCR products (Fig. 3) : 1,225 bp from intron 4 of the RHCE gene, 576 bp from intron 4 of the RHD gene, and 198 bp from exon 10 of the RHD gene. On the other hand, the patterns of PCR products from 130 RhD-negative donors could be classified into three categories of A, B, and C (Fig. 3 a, Table II ). Intron 4 of the RHCE gene was amplified in all RhD-negative donors. In category A, both PCR products from intron 4 and exon 10 of the RHD gene were absent (gross RHD gene deletion type). In category B, the PCR product was present in exon 10 of the RHD gene, but not in intron 4 of the RHD gene (partial RHD gene deletion type). In category C, all three PCR products were detectable (RHD gene nondeletion type). Among 130 RhD-negative donors, 92 (70.8%), 2 (1.5%), and 36 (27.7%) were grouped into categories A, B, and C, respectively (Table II) . All 78 RhD-negative donors with RhCnegative and Rhc-positive phenotypes showed category A. 52 RhD-negative donors with RhC-positive phenotypes were divided into 14 (26.9%) of category A, 2 (3.9%) of category B, and 36 (69.2%) of category C. The presence of the RHD gene in RhD-negative donors seems to relate strictly to the RhC phenotypes, but not to the Rhc, RhE, or Rhe. As shown in Fig.  1 , the dual PCRII by two sets of F1/R1 and F5/R5, and the triple PCR by three primer sets of F1/R1, F2/R2, and F4/R4 were performed for 200 RhD-positive donors. In all donors, two bands and three bands were detected in the products of the dual PCRII and triple PCR, respectively (Fig. 3, b and c) . Two bands in the dual PCRII consisted of 180 bp from exon 2 of both the RHD and RHCE genes, and 95 bp from exon 7 of the RHD gene. The dual PCRII and triple PCR were applied to 130 RhD-negative donors. Both of these PCR supported the result of the dual PCRI and the classification of categories A, B, and C. One of two donors belonging to category B lacked all PCR products from exons 3, 5, and 7 of the RHD gene (not shown), and the other possessed only that of exon 3 (Fig. 3) . There appeared to be various size deletions of the RHD gene in the partial RHD deletion type.
Southern blot analysis.
Southern analysis was performed to analyze further the structure of the RH locus. BamHI was used as a restriction endonuclease. 2), respectively. The 4.3-kb band appears to be derived from the RHD gene, and this result is the same as previous reports (1, 26) .
Isolation and sequencing of cDNA-encoding Rh polypeptides. Detection of Rh polypeptide mRNA has been accomplished using the RT-PCR method followed by direct sequencing. The RT-PCR using Taq DNA polymerase was performed for the Rh polypeptide cDNAs from 12 RhD-negative donors with the RHD gene, and 6 RhD-negative donors without the RHD gene using a set of 1s/1a primers. After 35 cycles of amplification, the reaction products were separated by agarose gel electrophoresis, and the fractionated bands were detected in all samples (around 1,313 bp expected). Direct sequencing suggested the presence of RhD-cDNA in PCR products from all the RhD-negative donors with the RHD gene, but not in ones from the RhD-negative donors without the RHD gene. For the purpose of purification of the Rh-related cDNAs, the RT-PCR products were subcloned with the plasmid pCRTM Isolation and sequencing of the promoter region of RH genes. The PCR amplification was performed for the 5Ј flanking regions containing the promoters of the RHD and RHCE genes from three RhD-positive donors and three RhD-negative donors with both genes. The sequences of these PCR products clarified no substitution between the flanking regions of the RHD and RHCE genes, not only from the RhD-positive donors, but also from the RhD-negative donors.
Discussion
Several theories were put forward on RH genetic models until the present. At first, the three-loci theory was proposed by Fisher and Race (27) . This theory has contributed greatly to understanding the hereditary manner in the Rh blood group system. Furthermore, Fisher (28, 29) , by analyzing the frequency ratio of each genotype, postulated that the RHC/c gene lies between the RHD and RHE/e genes. Wiener (30) , on the other hand, suggested the single locus theory, in which the inheritance of Rh antigens is determined by a single gene with multiple alleles. Thereafter, the two-loci theory was advocated by Tippett (31) , based on serological data. According to this model, RH genes consist of two structural genes: one encoding the RhD antigen, and the other encoding both the RhC/c and RhE/e antigens. Actually, two different RH-cDNAs (RHD and RHCE cDNAs) were cloned (2, 3, 15, 19, 20) . By Southern analysis of genomic DNA, Colin et al.
(1) indicated that two highly homologous genes were present in RhD-positive individuals, but that only one was present in RhD-negative individuals. Absence of the RHD gene in RhD-negative individuals was confirmed after cloning of the RHD-cDNA (2, 3) . These reports are compatible with the two-loci theory. The present data, however, demonstrated the normal RHD gene in 36 (27.7%) of 130 RhD-negative Japanese donors. We used every discretion in determining the RhD-negative phenotypes for excluding partial D, D u , or D el antigen. All of these RhD-negative donors with the RHD gene showed the CC or Cc phenotypes, but not the cc phenotype. These results suggest that there is some relationship between the RHD gene and the RhC phenotypes in RhD-negative individuals. As an exception, the RHD gene had been isolated from a Japanese sibling with the phenotype of ccdee (16) . It was suggested that another mechanism preventing the expression of RhD antigen might participate in the previously reported case. In RhD-negative Caucasians, the RHD gene has not been found outside of the report of Hyland et al. (14) . By performing careful research, it is possible to detect the RHD gene in RhD-negative Caucasians. The frequency of RhD-negative phenotype varies widely in different parts of the world, presenting itself in 17% of English people (22) , but only in 0.5% of the Japanese (32). The RhC-positive phenotypes accounted for 18% of Japanese RhD-negatives, but only for a very low percentage of English RhD-negatives. The diverse data on the RHD gene of RhD-negative individuals seem to be due to the difference of RhD-negative and RhC-positive frequency between both races. In the present study, the number of RhD-negative and RhCpositive donors was biased because these donors were analyzed actively with the intention of comparing with RhD-negative and RhC-negative donors. With due regard to the percentage (69.2%) of the presence of RHD gene in the RhD-negative and RhC-positive individuals, the positive ratio of the RHD gene in Japanese RhD negatives is estimated to be 12.5%.
The blood group antigenicity of the Rh-related polypeptides is thought to require one or more comolecules (33, 34) . The candidates for the Rh-related comolecules included the Rh50 glycoprotein, LW glycoprotein, glycophorin B, CD47 glycoprotein, and Duffy glycoprotein (33, 34) . Among them, Cherif-Zahar et al. (35) have proposed the Rh50 glycoprotein as a comolecule common to the RhD and RhCE polypeptides through investigating five Rhnull individuals whose red cells lacked all antigens (D, C/c, and E/e) of the Rh system. In these Rhnull cases, the Rh50 glycoproteins have shown genomic alterations of frameshift, nucleotide mutations, and failure of amplification. The Rh50 glycoproteins that were immunoprecipitated by Moore and Green (36) are heterogeneously glycosylated membrane proteins of 50 and 45 kD, coprecipitated with the Rh30 protein on immunoprecipitation with antiRh-specific antibodies (37) . It is thought that the Rh30 polypeptide, which is a nonglycosylated 30-kD erythrocyte membrane protein, is associated with Rh antigen (38) . Confirmation of the RhD-negative phenotype with the intact RHD gene, and of the -D-phenotype with the intact RHCE gene, predicts RhD-specific and RhCE-specific comolecules. In several RhD-negative cases with the RHD gene, it was shown in this time that the promoter regions of both RH genes were intact, and that each RHD-cDNA obtained from them was also intact. In several RhD-negative donors without the RHD gene, RHD-cDNA was entirely absent. We have also indicated normal Rh50 transcripts in RhD-negative donor reticulocyte (not shown). By carrying out the coexpression study of Rh50 and RHD or RHCE gene in 293 nonerythroid cells, we confirmed that excessive transcript was shown with Northern blotting study, in spite of the lack of RhD and RhC antigens on transduced cells (manuscript submitted for publication). We intend to detect RhD-specific comolecules, and to analyze the mechanism of the expression in RhD-negative cases with the RHD gene. The RhD-specific and RhCE-specific comolecules have not been isolated. The present data suggested that the gene of the RhD-specific comolecule that was associated with the expression of RhD-polypeptide correlated with the RHCE or RHCe gene. The genetic change of the RhD-specific comolecule might induce the disappearance of RhD antigen on red cell membranes.
According to the above-mentioned data, it is probable that the RHD gene is highly detected in other ethnic RhD-negative groups, especially with RhC-positive phenotype, as well as Japanese. It is dangerous to perform RhD genotyping by judging the absence or the presence of the RHD gene. In applying RhD genotyping to clinical medicine, careful attention is necessary for clinicians. As RhD genotyping must inevitably be carried out to investigate the fetal RhD type before birth for making a rapid diagnosis and achieving a good prognosis, for instance, HDN case, the clinicians have to recognize its limitation and take notice of the interpretation on its result. It is thought that further research in the Rh blood system is necessary to apply the RhD genotyping to clinical medicine in a safer manner.
